Home
Md Jubayer al Hossain's picture

Md Jubayer al Hossain

Researcher, Post-doc Fellow
  1. Hossain JA, Miletic H. Letter regarding “Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas”. Neuro Oncol . 2020 

  2. Hossain JA, Marchini A, Fehse B, Bjerkvig R and Miletic H. Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects. Neurooncol Adv. 2020

  3. Hossain JA, Ystaas LAR, Latif MA, Ninzima S, Joseph JV, Talasila KM, Ghimire J, Riecken K, Fehse B, Bjerkvig R and Miletic H. Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma, (Neuro Oncol., 2019, In Press). 

  4. Hossain JA, Riecken K, Miletic H, Fehse B. Cancer Suicide Gene Therapy with TK.007. Methods Mol Biol. 2019;1895:11-26. 
  5. Hossain JA, Ystaas LR, Mrdalj J, Välk K, Riecken K, Fehse B, Bjerkvig R, Grønli J,Miletic H. Lentiviral HSV-Tk.007 mediated suicide gene therapy is not toxic for normal brain cells. J Gene Med. 2016 Sep;18(9):234-43. 
  6. Talasila KM, Røsland GV, Hagland HR, Eskilsson E, Flønes IH Fritah S, Azuaje F, Atai, N, Harter PN, Mittelbronn M, Andersen M, Joseph JV, Hossain JA, Vallar L, van Noorden CJF, Niclou SP, Thorsen F, Tronstad KJ, Tzoulis C, Bjerkvig R and Miletic H. The angiogenic switch leads to a metabolic shift in human glioblastoma. Neuro Oncol. 2017 Mar 1;19(3):383-393. 
  7. Eskilsson E, Rosland GV, Talasila KM, Knappskog S, Keunen O, Sottoriva A, Foerster S, Solecki G, Taxt T, Jirik R, Fritah S, Harter PN, Välk K, Al Hossain J, Joseph JV, Jahedi R, Saed HS, Piccirillo SG, Spiteri I, Euskirchen P, Graziani G, Daubon T, Lund-Johansen M, Enger PØ, Winkler F, Ritter CA, Niclou SP, Watts C, Bjerkvig R, Miletic H. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. Neuro Oncol. 2016 Dec;18(12):1644-1655. Epub 2016 Jun 10. 
  8. Samoylenko A*, Hossain JA*, Mennerich D, Kellokumpu S, Hiltunen JK, Kietzmann T. Nutritional Countermeasures Targeting Reactive Oxygen Species in Cancer: From Mechanisms to Biomarkers and Clinical Evidence. Antioxid Redox Signal. 2013 Dec 10; 19(17): 2157–2196. *Co-first author. 
Academic article
  • Show author(s) 2020. Letter regarding "Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas". Neuro-Oncology. 1882-1883.
  • Show author(s) 2019. Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma. Neuro-Oncology. 890-900.
  • Show author(s) 2017. The angiogenic switch leads to a metabolic shift in human glioblastoma. Neuro-Oncology. 383-393.
  • Show author(s) 2016. Lentiviral HSV-Tk.007-mediated suicide gene therapy is not toxic for normal brain cells. Journal of Gene Medicine. 234-243.
  • Show author(s) 2016. EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation. Neuro-Oncology. 1644-1655.
Masters thesis
  • Show author(s) 2020. Studies on the Molecular Mechanisms of the Bystander Effect in HSV-TK mediated Suicide Gene Therapy for Glioblastoma Treatment.
  • Show author(s) 2019. Use of Gap Junction Enhanching Drugs to Increase the Bystander Effect of Sucide Gene Therapy for Glioblastoma Treatment.
  • Show author(s) 2017. Screening of tumor suppressor microRNAs to boost the killing efficacy of suicide gene therapy for brain cancer treatment.
Academic chapter/article/Conference paper
  • Show author(s) 2019. Cancer Suicide Gene Therapy with TK.007. 16 pages.
Academic literature review
  • Show author(s) 2020. Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects. Neuro-Oncology Advances (NOA).

More information in national current research information system (CRIStin)

  • Suicide Gene Therapy for the Treatment of Brain tumors
  • Oncolytic Virotherapy by H1 PV Virus for the Treatment of Various Cancers
  • Molecular Mechanism of Bystander effect in HSV-TK/GCV Gene therapy

Research groups